ArticleThe New England journal of medicine2016
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia.
Andrew W Roberts et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1,010 papers cite itlatest 60 shown
this paperpooled ittrialcites it